President and Senior Statistical Scientist at Berry Consultants, widely regarded as the premier Bayesian consulting company in the world. Specialist in clinical trial simulation and construction of adaptive designs.

Over 30 years’ experience in clinical trials. Authored key guidelines, including the NIHR Clinical Trials Toolkit and Australian Clinical Trials Handbook. Focused on aligning trials with global best practices, embedding them into health systems, and advancing consumer involvement.

Director of the Cardiac Intensive Care Unit at the McGill University Health Centre in Montreal and an Associate Professor of Medicine at McGill and the University of Toronto. Extensive experience with Bayesian adaptive platform trials, as well as identification of heterogeneity of treatment effect, observational clinical epidemiology and translational research.

Academic Paediatric Intensive Care and Infectious Diseases Physician at the University of British Columbia. Experienced in designing and implementing innovative clinical trials across diverse care settings and resource environments, from outpatients to critically ill patients.

Medical Director, Rare Care Centre, Perth Children’s Hospital. Founding Board Member, Undiagnosed Diseases Network International. Co-Founder of innovative programs like Cliniface, Lyfe Languages and the Global Nursing Network for Rare Disease - equitably advancing rare disease diagnosis, care and global partnership.

Senior intensive care specialist, former Clinical Director of Critical Care Medicine at Te Toka Tumai Auckland Hospital and a past Chair of the ANZICS Clinical Trials Group. Currently leads research governance at New Zealand’s largest clinical research facility, and has research interests in adaptive platform trial design and analysis, and severe respiratory infections.

Clinical Immunologist and Infectious Diseases Physician at Te Toka Tumai Auckland Hospital and Programme Lead at the Medical Research Institute of New Zealand. Focuses on adaptive platform trial design and managing infections in critically ill and immuno-compromised patients.

Paul is Co-Director and Clinical Trials Unit Director at ICNARC, UK. An experienced epidemiologist, he specialises in designing, conducting, and coordinating large-scale adaptive platform trials and leveraging routinely collected data in clinical research.

Mitch has dedicated over 40 years to health consumer advocacy, championing a shift towards research and healthcare that prioritises consumer needs over service providers and policymakers. He is the 2024 Western Australian of the Year Community Winner.

Renowned leader in consumer engagement with over 30 years experience. Anne has guided national programs, advised the NHMRC and Department of Health, and trained thousands in community-focused health research. Champion for inclusive research practices across Australia.

Infectious diseases physician at Royal Melbourne Hospital and Professor at the University of Melbourne. Leads adaptive platform trials on Staphylococcus aureus and acute respiratory tract infections. Also studies the burden of infectious diseases in Australian First Nations people.

Critical care nurse researcher. Head, critical care program, The George Institute for Global Health. More than 20 years’ experience designing, leading and operationalising large-scale epidemiological studies and clinical trials in high- and low-income country settings. Holds executive and board roles within local health districts and not-for-profit organisations.